Oligodendrocyte lineage is severely affected in human alcohol-exposed foetuses.
Autorzy:
MarguetF; Department of Pathology, Normandy Centre for Genomic and Personalized Medicine, Laboratoire d'Anatomie Pathologique, Pavillon Jacques Delarue, CHU, Normandie Univ, UNIROUEN, INSERM U1245 and Rouen University Hospital, 1 Rue de Germont, 76031, Rouen Cedex, France. florent.marguet@hotmail.fr. Brosolo M; UNIROUEN, INSERM U1245 F76000, Normandy Centre for Genomic and Personalized Medicine, Normandie Univ, Rouen, France. Friocourt G; Inserm UMR1078, Université de Bretagne Occidentale, Faculté de Médecine et Des Sciences de la Santé; Etablissement Français du Sang (EFS) Bretagne; Laboratoire de Génétique Moléculaire, CHRU Brest, Hôpital Morvan, Brest, France. Sauvestre F; Department of Pathology, Bordeaux University Hospital, Bordeaux, France. Marcorelles P; Pathology Laboratory, Pole Pathologie-Biologie, Centre Hospitalier Universitaire Brest, Brest, France.; Laboratory of Neurosciences of Brest, Faculté de Médecine et des Sciences de la Santé, Brest University, Brest, France. Lesueur C; UNIROUEN, INSERM U1245 F76000, Normandy Centre for Genomic and Personalized Medicine, Normandie Univ, Rouen, France. Marret S; Department of Neonatal Paediatrics and Intensive Care, Normandy Centre for Genomic and Personalized Medicine, Normandie Univ, UNIROUEN, INSERM U1245 and Rouen University Hospital, 76000, Rouen, France. Gonzalez BJ; UNIROUEN, INSERM U1245 F76000, Normandy Centre for Genomic and Personalized Medicine, Normandie Univ, Rouen, France. Laquerrière A; Department of Pathology, Normandy Centre for Genomic and Personalized Medicine, Laboratoire d'Anatomie Pathologique, Pavillon Jacques Delarue, CHU, Normandie Univ, UNIROUEN, INSERM U1245 and Rouen University Hospital, 1 Rue de Germont, 76031, Rouen Cedex, France.
A postzygotic de novo NCDN mutation identified in a sporadic FTLD patient results in neurochondrin haploinsufficiency and altered FUS granule dynamics.
Autorzy:
Nicolas G; Inserm U1245 and CHU Rouen, Department of Genetics and CNR-MAJ, Normandie University, UNIROUEN, F-76000, Rouen, France. Sévigny M; Department of Psychiatry and Neuroscience, Laval University, Quebec City, QC, Canada, 2325, rue de l'Université, G1V 0A6.; CERVO Brain Research Centre, Laval University, Quebec City, QC, Canada, 2601, chemin de la Canardière, G1J 2G3. Lecoquierre F; Inserm U1245 and CHU Rouen, Department of Genetics and CNR-MAJ, Normandie University, UNIROUEN, F-76000, Rouen, France. MarguetF; Inserm U1245 and CHU Rouen, Department of Pathology, Normandie University, UNIROUEN, F-76000, Rouen, France. Deschênes A; Department of Psychiatry and Neuroscience, Laval University, Quebec City, QC, Canada, 2325, rue de l'Université, G1V 0A6.; CERVO Brain Research Centre, Laval University, Quebec City, QC, Canada, 2601, chemin de la Canardière, G1J 2G3.; Department of Biochemistry, Microbiology and Bioinformatics, Laval University, Quebec City, QC, Canada. Del Pelaez MC; Department of Psychiatry and Neuroscience, Laval University, Quebec City, QC, Canada, 2325, rue de l'Université, G1V 0A6.; CERVO Brain Research Centre, Laval University, Quebec City, QC, Canada, 2601, chemin de la Canardière, G1J 2G3. Feuillette S; Inserm U1245 and CHU Rouen, Department of Genetics and CNR-MAJ, Normandie University, UNIROUEN, F-76000, Rouen, France. Audebrand A; Department of Psychiatry and Neuroscience, Laval University, Quebec City, QC, Canada, 2325, rue de l'Université, G1V 0A6.; CERVO Brain Research Centre, Laval University, Quebec City, QC, Canada, 2601, chemin de la Canardière, G1J 2G3. Lecourtois M; Inserm U1245 and CHU Rouen, Department of Genetics and CNR-MAJ, Normandie University, UNIROUEN, F-76000, Rouen, France. Rousseau S; Inserm U1245 and CHU Rouen, Department of Genetics and CNR-MAJ, Normandie University, UNIROUEN, F-76000, Rouen, France. Richard AC; Inserm U1245 and CHU Rouen, Department of Genetics and CNR-MAJ, Normandie University, UNIROUEN, F-76000, Rouen, France. Cassinari K; Inserm U1245 and CHU Rouen, Department of Genetics and CNR-MAJ, Normandie University, UNIROUEN, F-76000, Rouen, France. Deramecourt V; Lille Neuroscience and Cognition (Inserm UMRS1172) Alzheimer and Tauopathies, Laboratory of Excellence Distalz (Development of Innovative Strategies for a Transdisciplinary Approach to ALZheimer's Disease), University of Lille, CHU Lille, Lille, France.; Department of Neuropathology, University of Lille, CHU Lille, Lille, France. Duyckaerts C; INSERM, CNRS U1127, Institut du Cerveau, Sorbonne Université, ICM, Paris, France.; Laboratoire de Neuropathologie R. Escourolle, AP-HP, Hôpital de la Pitié-Salpêtrière, Paris, France. Boland A; CEA, Centre National de Recherche en Génomique Humaine, Université Paris-Saclay, 91057, Evry, France. Deleuze JF; CEA, Centre National de Recherche en Génomique Humaine, Université Paris-Saclay, 91057, Evry, France. Meyer V; CEA, Centre National de Recherche en Génomique Humaine, Université Paris-Saclay, 91057, Evry, France. Clarimon Echavarria J; Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. Gelpi E; Neurological Tissue Bank of the Biobank-Hospital Clinic-IDIBAPS, Barcelona, Spain.; Division of Neuropathology, Department of Neurology, Medical University of Vienna, Vienna, Austria. Akiyama H; Dementia Research Project, Department of Brain and Neurosciences, Tokyo Metropolitan Institute of Medical Science, Setagaya City, Japan. Hasegawa M; Dementia Research Project, Department of Brain and Neurosciences, Tokyo Metropolitan Institute of Medical Science, Setagaya City, Japan. Kawakami I; Dementia Research Project, Department of Brain and Neurosciences, Tokyo Metropolitan Institute of Medical Science, Setagaya City, Japan. Wong TH; Department of Neurology and Alzheimer Center, Erasmus Medical Center, Rotterdam, The Netherlands. Van Rooij JGJ; Department of Neurology and Alzheimer Center, Erasmus Medical Center, Rotterdam, The Netherlands. Van Swieten JC; Department of Neurology and Alzheimer Center, Erasmus Medical Center, Rotterdam, The Netherlands.; Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands. Campion D; Inserm U1245 and CHU Rouen, Department of Genetics and CNR-MAJ, Normandie University, UNIROUEN, F-76000, Rouen, France. Dutchak PA; Department of Psychiatry and Neuroscience, Laval University, Quebec City, QC, Canada, 2325, rue de l'Université, G1V 0A6.; CERVO Brain Research Centre, Laval University, Quebec City, QC, Canada, 2601, chemin de la Canardière, G1J 2G3. Wallon D; UNIROUEN, Inserm U1245 and CHU Rouen, Department of Neurology and CNR-MAJ, Normandie University, F-76000, Rouen, France. Lavoie-Cardinal F; Department of Psychiatry and Neuroscience, Laval University, Quebec City, QC, Canada, 2325, rue de l'Université, G1V 0A6.; CERVO Brain Research Centre, Laval University, Quebec City, QC, Canada, 2601, chemin de la Canardière, G1J 2G3.; Institut Intelligence et Données, Laval University, Quebec City, QC, Canada. Laquerrière A; Inserm U1245 and CHU Rouen, Department of Pathology, Normandie University, UNIROUEN, F-76000, Rouen, France. Rovelet-Lecrux A; Inserm U1245 and CHU Rouen, Department of Genetics and CNR-MAJ, Normandie University, UNIROUEN, F-76000, Rouen, France. . Sephton CF; Department of Psychiatry and Neuroscience, Laval University, Quebec City, QC, Canada, 2325, rue de l'Université, G1V 0A6. .; CERVO Brain Research Centre, Laval University, Quebec City, QC, Canada, 2601, chemin de la Canardière, G1J 2G3. .
Neuropathological hallmarks of fetal hydrocephalus linked to CCDC88C pathogenic variants.
Autorzy:
MarguetF; UNIROUEN, INSERM U1245, Rouen University Hospital, Department of Pathology, Normandie Univ, 76000, Rouen, France. Vezain M; UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Genetics and Reference Center for Developmental Disorders, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, 76000, Rouen, France. Marcorelles P; UBO EA 4685 LIEN and Brest University Hospital, Pathology Department, Brest Univ, 29609, Brest, France. Audebert-Bellanger S; Department of Genetics, Brest University Hospital, 29200, Brest, France. Cassinari K; UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Genetics and Reference Center for Developmental Disorders, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, 76000, Rouen, France. Drouot N; UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Genetics and Reference Center for Developmental Disorders, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, 76000, Rouen, France. Chambon P; UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Genetics and Reference Center for Developmental Disorders, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, 76000, Rouen, France. Gonzalez BJ; UNIROUEN, INSERM U1245, Normandy Centre for Genomic and Personalized Medicine, Normandie Univ, 76000, Rouen, France. Horowitz A; UNIROUEN, INSERM U1245, Normandy Centre for Genomic and Personalized Medicine, Normandie Univ, 76000, Rouen, France. Laquerriere A; UNIROUEN, INSERM U1245, Rouen University Hospital, Department of Pathology, Normandie Univ, 76000, Rouen, France. .; Pathology Laboratory, Pavillon Jacques Delarue, CHR, 1 rue de Germont, 76031, Rouen Cedex, France. . Saugier-Veber P; UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Genetics and Reference Center for Developmental Disorders, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, 76000, Rouen, France.
Cell-free DNA and circulating TERT promoter mutation for disease monitoring in newly-diagnosed glioblastoma.
Autorzy:
Fontanilles M; Inserm U1245, Normandie Univ, UNIROUEN, IRON group, Normandy Centre for Genomic and Personalized Medicine, Rouen, France. .; Department of Medical Oncology, Cancer Centre Henri Becquerel, Rue d'Amiens, 76000, Rouen, France. .; Département d'oncologie médicale, Centre de Lutte Contre le Cancer Henri Becquerel, Rue d'Amiens, 76038, Rouen, France. . MarguetF; Normandie Univ, UNIROUEN, Inserm U1245, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.; Department of Pathology, Rouen University Hospital, 76031, Rouen, France. Beaussire L; Inserm U1245, Normandie Univ, UNIROUEN, IRON group, Normandy Centre for Genomic and Personalized Medicine, Rouen, France. Magne N; Department of Radiology, Rouen University Hospital, 76031, Rouen, France. Pépin LF; Department of Statistics and Clinical Research Unit, Henri Becquerel Cancer Center, Rouen, France. Alexandru C; Department of Medical Oncology, Cancer Centre Henri Becquerel, Rue d'Amiens, 76000, Rouen, France. Tennevet I; Department of Medical Oncology, Cancer Centre Henri Becquerel, Rue d'Amiens, 76000, Rouen, France. Hanzen C; Department of Radiation Oncology and Medical Physics, Cancer Centre Henri Becquerel, Rue d'Amiens, 76000, Rouen, France. Langlois O; Department of Neurosurgery, Rouen University Hospital, 76031, Rouen, France. Jardin F; Normandie Univ, UNIROUEN, Inserm U1245, Normandy Centre for Genomic and Personalized Medicine, Rouen, France. Laquerrière A; Normandie Univ, UNIROUEN, Inserm U1245, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.; Department of Pathology, Rouen University Hospital, 76031, Rouen, France. Sarafan-Vasseur N; Inserm U1245, Normandie Univ, UNIROUEN, IRON group, Normandy Centre for Genomic and Personalized Medicine, Rouen, France. Di Fiore F; Inserm U1245, Normandie Univ, UNIROUEN, IRON group, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.; Department of Medical Oncology, Cancer Centre Henri Becquerel, Rue d'Amiens, 76000, Rouen, France.; Department of Gastroenterology, Rouen University Hospital, 76031, Rouen, France. Clatot F; Inserm U1245, Normandie Univ, UNIROUEN, IRON group, Normandy Centre for Genomic and Personalized Medicine, Rouen, France.; Department of Medical Oncology, Cancer Centre Henri Becquerel, Rue d'Amiens, 76000, Rouen, France.
Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma.
Autorzy:
Fontanilles M; Inserm U1245, Normandie Univ, UNIROUEN, IRON group, Normandy Centre for Genomic and Personalized Medicine, Rouen University Hospital, F-76031, Rouen, France. .; Department of Medical Oncology, Cancer Centre Henri Becquerel, Rue d'Amiens, F-76038, Rouen, France. . MarguetF; Inserm U1245, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, Rouen University Hospital, F-76031, Rouen, France.; Department of Pathology, Rouen University Hospital, F-76031, Rouen, France. Ruminy P; Inserm U1245, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, Rouen University Hospital, F-76031, Rouen, France. Basset C; Department of Pathology, Rouen University Hospital, F-76031, Rouen, France. Noel A; Inserm U1245, Normandie Univ, UNIROUEN, IRON group, Normandy Centre for Genomic and Personalized Medicine, Rouen University Hospital, F-76031, Rouen, France. Beaussire L; Inserm U1245, Normandie Univ, UNIROUEN, IRON group, Normandy Centre for Genomic and Personalized Medicine, Rouen University Hospital, F-76031, Rouen, France. Viennot M; Inserm U1245, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, Rouen University Hospital, F-76031, Rouen, France. Viailly PJ; Department of Pathology, Rouen University Hospital, F-76031, Rouen, France. Cassinari K; Department of Genetics, Inserm U1245, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, Rouen University Hospital, F-76031, Rouen, France. Chambon P; Department of Genetics, Inserm U1245, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, Rouen University Hospital, F-76031, Rouen, France. Richard D; Department of Statistics and Clinical Research Unit, Cancer Centre Henri Becquerel, Rouen, F-76038, France. Alexandru C; Department of Medical Oncology, Cancer Centre Henri Becquerel, Rue d'Amiens, F-76038, Rouen, France. Tennevet I; Department of Medical Oncology, Cancer Centre Henri Becquerel, Rue d'Amiens, F-76038, Rouen, France. Langlois O; Department of Neurosurgery, Rouen University Hospital, F-76031, Rouen, France. Di Fiore F; Inserm U1245, Normandie Univ, UNIROUEN, IRON group, Normandy Centre for Genomic and Personalized Medicine, Rouen University Hospital, F-76031, Rouen, France.; Department of Medical Oncology, Cancer Centre Henri Becquerel, Rue d'Amiens, F-76038, Rouen, France.; Department of Gastroenterology, Rouen University Hospital, F-76031, Rouen, France. Laquerrière A; Inserm U1245, Normandie Univ, UNIROUEN, Normandy Centre for Genomic and Personalized Medicine, Rouen University Hospital, F-76031, Rouen, France.; Department of Pathology, Rouen University Hospital, F-76031, Rouen, France. Clatot F; Inserm U1245, Normandie Univ, UNIROUEN, IRON group, Normandy Centre for Genomic and Personalized Medicine, Rouen University Hospital, F-76031, Rouen, France.; Department of Medical Oncology, Cancer Centre Henri Becquerel, Rue d'Amiens, F-76038, Rouen, France. Sarafan-Vasseur N; Inserm U1245, Normandie Univ, UNIROUEN, IRON group, Normandy Centre for Genomic and Personalized Medicine, Rouen University Hospital, F-76031, Rouen, France.
Foetal onset of EIF2B related disorder in two siblings: cerebellar hypoplasia with absent Bergmann glia and severe hypomyelination.
Autorzy:
Trimouille A; Department of Medical Genetics, Bordeaux University Hospital, Bordeaux, France.; Bordeaux Univ, INSERM U1211, Bordeaux University Hospital, Bordeaux, France. MarguetF; Normandie Univ, UNIROUEN, INSERM U1245, Rouen University Hospital, Department of Pathology, F76000, Rouen, France. Sauvestre F; Department of Pathology, Bordeaux University Hospital, Bordeaux, France. Lasseaux E; Department of Medical Genetics, Bordeaux University Hospital, Bordeaux, France. Pelluard F; Department of Pathology, Bordeaux University Hospital, Bordeaux, France. Martin-Négrier ML; Department of Pathology, Bordeaux University Hospital, Bordeaux, France. Plaisant C; Department of Medical Genetics, Bordeaux University Hospital, Bordeaux, France. Rooryck C; Department of Medical Genetics, Bordeaux University Hospital, Bordeaux, France.; Bordeaux Univ, INSERM U1211, Bordeaux University Hospital, Bordeaux, France. Lacombe D; Department of Medical Genetics, Bordeaux University Hospital, Bordeaux, France.; Bordeaux Univ, INSERM U1211, Bordeaux University Hospital, Bordeaux, France. Arveiler B; Department of Medical Genetics, Bordeaux University Hospital, Bordeaux, France.; Bordeaux Univ, INSERM U1211, Bordeaux University Hospital, Bordeaux, France. Boespflug-Tanguy O; INSERM UMR1141 Paris Diderot University, APHP Child neurology and Metabolic Department, Reference Centre for Leukodystrophies (LEUKOFRANCE -ERN-RND)- Robert-Debré hospital, Paris, France. Naudion S; Department of Medical Genetics, Bordeaux University Hospital, Bordeaux, France. Laquerrière A; Normandie Univ, UNIROUEN, INSERM U1245, Rouen University Hospital, Department of Pathology, F76000, Rouen, France. .; Pathology Laboratory, Pavillon Jacques Delarue,CHR, 1 rue de Germont, 76031, Rouen, Cedex, France. .
Mosaic PTEN alteration in the neural crest during embryogenesis results in multiple nervous system hamartomas.
Autorzy:
Goldenberg A; Department of Genetics, Rouen University Hospital and Normandie Univ, UNIROUEN, Inserm U1245, Normandy Centre for Genomic and Personalized Medicine, F76000, Rouen, France. MarguetF; Department of Pathology, Rouen University Hospital, F76000, Rouen, France. Gilard V; Department of Neurosurgery, Rouen University Hospital, F76000, Rouen, France. Cardine AM; Department of Paediatric Oncology, Rouen University Hospital, F76000, Rouen, France. Hassani A; Department of Radiology, Rouen University Hospital, F76000, Rouen, France. Doz F; Oncology Center SIREDO, Institute Curie and University Paris Descartes, F75000, Paris, France. Radi S; Team for Child Development, F76130, Mont Saint-Aignan, France. Vasseur S; Department of Genetics, Rouen University Hospital and Normandie Univ, UNIROUEN, Inserm U1245, Normandy Centre for Genomic and Personalized Medicine, F76000, Rouen, France. Bou J; Department of Genetics, Rouen University Hospital and Normandie Univ, UNIROUEN, Inserm U1245, Normandy Centre for Genomic and Personalized Medicine, F76000, Rouen, France. Branchaud M; Department of Genetics, Rouen University Hospital and Normandie Univ, UNIROUEN, Inserm U1245, Normandy Centre for Genomic and Personalized Medicine, F76000, Rouen, France. Houdayer C; Department of Genetics, Rouen University Hospital and Normandie Univ, UNIROUEN, Inserm U1245, Normandy Centre for Genomic and Personalized Medicine, F76000, Rouen, France. Baert-Desurmont S; Department of Genetics, Rouen University Hospital and Normandie Univ, UNIROUEN, Inserm U1245, Normandy Centre for Genomic and Personalized Medicine, F76000, Rouen, France. Laquerriere A; Department of Pathology, Rouen University Hospital, F76000, Rouen, France. Frebourg T; Department of Genetics, Rouen University Hospital and Normandie Univ, UNIROUEN, Inserm U1245, Normandy Centre for Genomic and Personalized Medicine, F76000, Rouen, France. .
Hydrocephalus due to multiple ependymal malformations is caused by mutations in the MPDZ gene.
Autorzy:
Saugier-Veber P; Department of Genetics, Normandie Univ, UNIROUEN, INSERM U1245, Normandy Centre for Genomic and Personalized Medicine, Rouen University Hospital, F76000, Rouen, France. MarguetF; Department of Pathology, Normandie Univ, UNIROUEN, INSERM U1245, Rouen University Hospital, F76000, Rouen, France. Lecoquierre F; Department of Genetics, Normandie Univ, UNIROUEN, INSERM U1245, Normandy Centre for Genomic and Personalized Medicine, Rouen University Hospital, F76000, Rouen, France. Adle-Biassette H; Department of Pathology, Lariboisière Hospital, APHP, F75000, Paris Diderot University, Sorbonne Paris Cité, PROTECT INSERM, F75019, Paris, France. Guimiot F; Department of Genetics and Cytogenetics, Foetopathology Unit, Robert Debré Hospital, APHP, Paris Diderot University, INSERM U1141, F75019, Paris, France. Cipriani S; Paris Diderot University, Sorbonne Paris Cité, PROTECT INSERM, F75019, Paris, France. Patrier S; Department of Pathology, Rouen University Hospital, F76000, Rouen, France. Brasseur-Daudruy M; Department of Radiology, Rouen University Hospital, F76000, Rouen, France. Goldenberg A; Department of Genetics, Normandy Centre for Genomic and Personalized Medicine, Rouen University Hospital, F76000, Rouen, France. Layet V; Department of Genetics and Cytogenetics, Le Havre Hospital, F76600, Le Havre, France. Capri Y; Department of Genetics, Robert Debré Hospital, APHP, F75019, Paris, France. Gérard M; Department of Genetics, Normandy Centre for Genomic and Personalized Medicine, Caen University Hospital, F14000, Caen, France. Frébourg T; Department of Genetics, Normandie Univ, UNIROUEN, INSERM U1245, Normandy Centre for Genomic and Personalized Medicine, Rouen University Hospital, F76000, Rouen, France. Laquerrière A; Department of Pathology, Normandie Univ, UNIROUEN, INSERM U1245, Rouen University Hospital, F76000, Rouen, France. .; Pathology Laboratory, Pavillon Jacques Delarue, CHR,1 rue de Germont, 76031, Rouen Cedex, France. .
HMGA2 immunostaining is a straightforward technique which helps to distinguish pulmonary fat-forming lesions from normal adipose tissue in small biopsies: a retrospective observational study about a series of 13 lung biopsies.
Autorzy:
Piton N; Department of Pathology, Rouen University Hospital, F 76 000 Rouen, France. . Angot É; Department of Pathology, Rouen University Hospital, F 76 000 Rouen, France. MarguetF; Department of Pathology, Rouen University Hospital, F 76 000 Rouen, France. Sabourin JC; Department of Pathology, Rouen University Hospital, F 76 000 Rouen, France.
Pokaż więcej
Źródło:
Diagnostic pathology [Diagn Pathol] 2017 Feb 23; Vol. 12 (1), pp. 21. Date of Electronic Publication: 2017 Feb 23.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies